Citadel Advisors’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$17.5M Buy
1,248,953
+79,270
+7% +$1.11M ﹤0.01% 1043
2025
Q1
$15.9M Buy
1,169,683
+339,772
+41% +$4.62M ﹤0.01% 1006
2024
Q4
$16.9M Buy
829,911
+52,631
+7% +$1.07M ﹤0.01% 1020
2024
Q3
$22.6M Sell
777,280
-441,418
-36% -$12.9M ﹤0.01% 800
2024
Q2
$28.3M Sell
1,218,698
-146,330
-11% -$3.4M 0.01% 715
2024
Q1
$28M Buy
1,365,028
+1,296,918
+1,904% +$26.6M 0.01% 735
2023
Q4
$1.46M Buy
68,110
+6,205
+10% +$133K ﹤0.01% 2682
2023
Q3
$1.28M Buy
61,905
+5,802
+10% +$120K ﹤0.01% 2816
2023
Q2
$1.66M Sell
56,103
-1,318,222
-96% -$38.9M ﹤0.01% 2571
2023
Q1
$31.7M Buy
1,374,325
+1,339,712
+3,871% +$30.9M 0.01% 638
2022
Q4
$963K Sell
34,613
-28,924
-46% -$804K ﹤0.01% 3247
2022
Q3
$1.95M Sell
63,537
-242,465
-79% -$7.44M ﹤0.01% 2766
2022
Q2
$9.01M Sell
306,002
-445,601
-59% -$13.1M ﹤0.01% 1355
2022
Q1
$24.2M Buy
751,603
+265,920
+55% +$8.55M 0.01% 790
2021
Q4
$21.7M Buy
485,683
+422,672
+671% +$18.9M ﹤0.01% 882
2021
Q3
$3.18M Buy
+63,011
New +$3.18M ﹤0.01% 2495
2021
Q2
Sell
-240,784
Closed -$13.7M 6518
2021
Q1
$13.7M Buy
240,784
+235,671
+4,609% +$13.5M ﹤0.01% 1197
2020
Q4
$428K Sell
5,113
-213,024
-98% -$17.8M ﹤0.01% 3974
2020
Q3
$7.82M Buy
218,137
+107,572
+97% +$3.85M ﹤0.01% 1252
2020
Q2
$2.67M Buy
110,565
+38,213
+53% +$924K ﹤0.01% 1985
2020
Q1
$1.27M Buy
72,352
+18,766
+35% +$329K ﹤0.01% 2644
2019
Q4
$933K Sell
53,586
-34,823
-39% -$606K ﹤0.01% 3050
2019
Q3
$1.35M Sell
88,409
-106,467
-55% -$1.63M ﹤0.01% 2682
2019
Q2
$4.05M Buy
194,876
+167,111
+602% +$3.47M ﹤0.01% 1823
2019
Q1
$645K Buy
+27,765
New +$645K ﹤0.01% 3188
2018
Q3
Sell
-49,421
Closed -$753K 4367
2018
Q2
$753K Buy
+49,421
New +$753K ﹤0.01% 2872